Literature DB >> 6321757

Characterization of La Crosse virus small-genome transcripts.

J L Patterson, D Kolakofsky.   

Abstract

With restriction fragments from DNA clones of the La Crosse virus S genome segment, the 3' end of the S mRNA was located by S1 nuclease mapping near a polyuridine tract, approximately 100 nucleotides, from the end of the S genome. Genome replication in La Crosse virus-infected cells was abolished by the drug cycloheximide, similar to other negative-strand RNA viruses. However, the synthesis of S mRNA could not be detected in cells pretreated with cycloheximide, suggesting that ongoing protein synthesis is required for La Crosse virus genome transcription and replication. Primer extension experiments in the presence of chain-terminating nucleoside triphosphates demonstrated that the 5' end of the La Crosse virus S mRNA begins 10 to 14 nucleotides before the 3' end of the S genome segment, suggesting that the La Crosse virus S mRNA is initiated on a host primer. A hypothesis consistent with these unexpected findings is presented.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6321757      PMCID: PMC255524     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  39 in total

1.  Sendai virus RNA synthesis and nucleocapsid formation in the presence of cycloheximide.

Authors:  W S Robinson
Journal:  Virology       Date:  1971-06       Impact factor: 3.616

2.  Identification of four complementary RNA species in Akabane virus-infected cells.

Authors:  A K Pattnaik; G Abraham
Journal:  J Virol       Date:  1983-09       Impact factor: 5.103

3.  Early RNA synthesis in Bunyamwera virus-infected cells.

Authors:  G Abraham; A K Pattnaik
Journal:  J Gen Virol       Date:  1983-06       Impact factor: 3.891

4.  Conserved polyadenylation signals in two negative-strand RNA virus families.

Authors:  K C Gupta; D W Kingsbury
Journal:  Virology       Date:  1982-07-30       Impact factor: 3.616

5.  Comparison of the sequences and coding of La Crosse and snowshoe hare bunyavirus S RNA species.

Authors:  H Akashi; D H Bishop
Journal:  J Virol       Date:  1983-03       Impact factor: 5.103

6.  Nucleotide sequences at the terminal of La Crosse virus RNAs.

Authors:  J F Obijeski; J McCauley; J J Skehel
Journal:  Nucleic Acids Res       Date:  1980-06-11       Impact factor: 16.971

7.  Multiple leader RNAs and messenger RNAs are transcribed from the La Crosse virus small genome segment.

Authors:  J L Patterson; C Cabradilla; B P Holloway; J F Obijeski; D Kolakofsky
Journal:  Cell       Date:  1983-07       Impact factor: 41.582

8.  The complete sequence and coding content of snowshoe hare bunyavirus small (S) viral RNA species.

Authors:  D H Bishop; K G Gould; H Akashi; C M Clerx-van Haaster
Journal:  Nucleic Acids Res       Date:  1982-06-25       Impact factor: 16.971

9.  Interferon action: inhibition of vesicular stomatitis virus RNA synthesis induced by virion-bound polymerase.

Authors:  P I Marcus; D L Engelhardt; J M Hunt; M J Sekellick
Journal:  Science       Date:  1971-11-05       Impact factor: 47.728

10.  Molecular cloning and sequencing of the La Crosse virus S RNA.

Authors:  C D Cabradilla; B P Holloway; J F Obijeski
Journal:  Virology       Date:  1983-07-30       Impact factor: 3.616

View more
  42 in total

1.  In vivo analysis of the TSWV cap-snatching mechanism: single base complementarity and primer length requirements.

Authors:  D Duijsings; R Kormelink; R Goldbach
Journal:  EMBO J       Date:  2001-05-15       Impact factor: 11.598

2.  RNA binding properties of bunyamwera virus nucleocapsid protein and selective binding to an element in the 5' terminus of the negative-sense S segment.

Authors:  J C Osborne; R M Elliott
Journal:  J Virol       Date:  2000-11       Impact factor: 5.103

3.  Signatures of host mRNA 5' terminus for efficient hantavirus cap snatching.

Authors:  Erdong Cheng; Mohammad A Mir
Journal:  J Virol       Date:  2012-07-11       Impact factor: 5.103

4.  Anti-mRNAs in La Crosse bunyavirus-infected cells.

Authors:  D Hacker; S Rochat; D Kolakofsky
Journal:  J Virol       Date:  1990-10       Impact factor: 5.103

5.  Bunyavirus mRNA synthesis is coupled to translation to prevent premature transcription termination.

Authors:  John N Barr
Journal:  RNA       Date:  2007-03-30       Impact factor: 4.942

6.  Expression of functional Bunyamwera virus L protein by recombinant vaccinia viruses.

Authors:  H Jin; R M Elliott
Journal:  J Virol       Date:  1991-08       Impact factor: 5.103

7.  Host-derived 5' ends and overlapping complementary 3' ends of the two mRNAs transcribed from the ambisense S segment of Uukuniemi virus.

Authors:  J F Simons; R F Pettersson
Journal:  J Virol       Date:  1991-09       Impact factor: 5.103

8.  Germiston virus transcriptase requires active 40S ribosomal subunits and utilizes capped cellular RNAs.

Authors:  P Vialat; M Bouloy
Journal:  J Virol       Date:  1992-02       Impact factor: 5.103

9.  Hantavirus nucleocapsid protein has distinct m7G cap- and RNA-binding sites.

Authors:  Mohammad A Mir; Sheema Sheema; Abdul Haseeb; Absarul Haque
Journal:  J Biol Chem       Date:  2010-02-17       Impact factor: 5.157

10.  Human and Murine IFIT1 Proteins Do Not Restrict Infection of Negative-Sense RNA Viruses of the Orthomyxoviridae, Bunyaviridae, and Filoviridae Families.

Authors:  Amelia K Pinto; Graham D Williams; Kristy J Szretter; James P White; José Luiz Proença-Módena; Gai Liu; Judith Olejnik; James D Brien; Hideki Ebihara; Elke Mühlberger; Gaya Amarasinghe; Michael S Diamond; Adrianus C M Boon
Journal:  J Virol       Date:  2015-07-08       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.